RayKnowChina Research Map
Shortlist

Tianjin

TEDA International Cardiovascular Hospital

泰达国际心血管病医院

Listed for 2 of the 61 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at TEDA International Cardiovascular Hospital

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 61 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Coronary heart disease冠心病7 papers led
  2. Congenital heart disease先天性心脏病4 papers led

Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Lung cancer, Pancreatic cancer, Breast cancer, Glioma, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Lymphoma, Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Scoliosis, Anti-NMDA receptor encephalitis, Takayasu arteritis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Other diseases

Coronary heart disease

冠心病

Led 7 of the 5,119 English-language PubMed papers on coronary heart disease with an author in mainland China, 2021–2025: 0.1%.

Papers led
7
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
1
led by another institution
Papers led per year
2021: 3320212022: 0020222023: 1120232024: 2220242025: 112025

9 hospitals in Tianjin for coronary heart disease231 hospitals in China for coronary heart disease

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 18 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
    Phase
    Phase 3
    Started
    2025-11
    Posted
    Registry
    NCT07439133

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 4 listed hospitals as study sitesBeijing, Tianjin

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
Departments in papersRadiology / nuclear medicinePathology / laboratory medicine

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led7
  1. Coronary Flow Reserve Measured by Myocardial Perfusion Imaging in Patients Following Percutaneous Coronary Intervention.2025Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & InterventionsFree full text
  2. Feasibility of myocardial blood flow quantification to detect flow-limited coronary artery disease with a one-day rest/stress continuous rapid imaging protocol on cardiac-dedicated cadmium zinc telluride single photon emission computed tomo2024Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
  3. Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG.2024The international journal of cardiovascular imagingFree full text
  4. Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.2023Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
  5. Current trends in optimal medical therapy after PCI and its influence on clinical outcomes in China.2021BMC cardiovascular disordersFree full text
  6. Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease.2021Chinese medical journalFree full text
  7. Diagnostic analysis of new quantitative parameters of low-dose dynamic myocardial perfusion imaging with CZT SPECT in the detection of suspected or known coronary artery disease.2021The international journal of cardiovascular imagingFree full text
Chinese-language papers (not in the count)3
  1. [Diagnostic efficiency and incremental value of myocardial blood flow quantification by CZT SPECT for patients with coronary artery disease].2022Zhonghua xin xue guan bing za zhi
  2. [The application status of optimal medical therapy after percutaneous coronary intervention and its influence on prognosis].2021Zhonghua yi xue za zhi
  3. [Study on the correlation between subgroup of blood lipid with degree of coronary artery stenosis in patients with coronary atherosclerotic heart disease].2021Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
All its trials on ClinicalTrials.gov, any status9
  1. Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)RecruitingNCT07439133Study sitePhase 3Start 2025-11
  2. Evaluate the Clinical Efficacy and Safety of Non-Compliant PTCA Balloon Dilatation CatheterCompletedNCT07855003Study siteStart 2026-07
  3. Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy ApparatusStatus unknownNCT05649488Study siteN/AStart 2023-02
  4. XTR003 PET Radiotracer for the Detection of Viable MyocardiumCompletedNCT05885854Study sitePhase 2Start 2021-12
  5. Loop Isolation-based Uploading Pre-conditioningStatus unknownNCT03766529Study siteStart 2016-01
  6. Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)Status unknownNCT02448524Study sitePhase 3Start 2015-07
  7. The EVOLVE China Clinical TrialCompletedNCT01966159Study siteN/AStart 2013-10
  8. Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ StentCompletedNCT01285999Study siteN/AStart 2011-01
  9. Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and TransfusionCompletedNCT01060163Study siteN/AStart 2010-01

Run the PubMed searchClinicalTrials.gov

Other diseases

Congenital heart disease

先天性心脏病

Led 4 of the 2,604 English-language PubMed papers on congenital heart disease with an author in mainland China, 2021–2025: 0.1%.

Papers led
4
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 2220212022: 1120222023: 1120232024: 0020242025: 002025

6 hospitals in Tianjin for congenital heart disease207 hospitals in China for congenital heart disease

No open trial on congenital heart disease lists this hospital on ClinicalTrials.gov on 18 Nov 2026.

The records behind these numbers
Departments in papersRadiology / nuclear medicinePathology / laboratory medicinePediatrics

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led4
  1. Anomalous origin of the left coronary artery from the pulmonary artery: The role of CZT camera.2023Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
  2. Anomalous origin of left coronary artery from the pulmonary artery in an adult woman with ischemia and steal phenomena.2022Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
  3. Genetic analysis of the CITED2 gene promoter in isolated and sporadic congenital ventricular septal defects.2021Journal of cellular and molecular medicineFree full text
  4. Growth and development of children under 5 years of age with tetralogy of Fallot in a Chinese population.2021Scientific reportsFree full text
Chinese-language papers (not in the count)1
  1. [Application Value of Plasma vWF and ADAMTS-13 in Evaluating Postoprative Vascular Endothelial Injury and Prognosis in Children with VSD].2023Zhongguo shi yan xue ye xue za zhi
All its trials on ClinicalTrials.gov, any status2
  1. Reoxygenation for Cyanotic Pediatric CHDStatus unknownNCT03568357Study siteStart 2012-01
  2. Perioperative Outcome of Congenital Heart Disease Surgery in ChildhoodStatus unknownNCT04093011Study siteStart 2012-01

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

泰达国际心血管病医院

TEDA International Cardiovascular Hospital

天津

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

ROR Wikidata
TEDA International Cardiovascular Hospital

Suggest a correctionDownload the data